Sortera Bio operates as a biotechnology company.
Sortera Bio has raised $10.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in June 2025.
Sortera Bio's investors include AstraZeneca, Cambridge Innovation Capital, BioNTech.
Sortera Bio is headquartered in Cambridge, United Kingdom.
Sortera Bio operates as a biotechnology company.
Sortera Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sortera Bio — Funding & Investors." VCBacked, June 5, 2025, https://www.vcbacked.co/company/sortera-bio. Accessed October 5, 2026.
VCBacked. (2025). Sortera Bio — Funding & Investors. Retrieved October 5, 2026, from https://www.vcbacked.co/company/sortera-bio
{{cite web |title=Sortera Bio — Funding & Investors |url=https://www.vcbacked.co/company/sortera-bio |website=VCBacked |access-date=October 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated